Page 7 - Mankind Pharma

Mankind Pharma inks distribution pact with BDR Pharma for Covid drug

Delhi-based Mankind Pharma operates in 34 overseas destinations.

Mankind Pharma eyes 50% revenue from chronic therapy drugs in 3 years

With the launch, the company has become the first Indian and second global firm to develop the drug, which is a generic version of Abbott's Duphaston

Mankind Pharma may partner RDIF for Russian Covid-19 vaccine Sputnik V

According to sources close to the development, talks are in advanced stages between Mankind Pharma and RDIF

Domestic drug market growth slows top 4.5% in January, some therapies drag

Respiratory segment and anti-infectives contract; Cardiac, anti-diabetic growth rates plummet

Mankind Pharma partners with South Korea's Daewoong for Covid drug

Will conduct clincial trials on anti-parasitic drug they claim is more effective than remdesivir

Mankind Pharma eyes acquisition of biotech firms, plans new launches

Mankind became the first Indian and second global company to develop a dydrogesterone containing drug for treatment of pregnancy-related complications

Mankind Pharma looking to achieve $1-bn turnover by 2021: Official

It has recently ventured into the US market with the filing of 12-15 ANDAs every year

Mankind Pharma set to foray into diagnostics with Pathkind

The company's initial focus will be Uttar Pradesh followed by Uttarakhand, Bihar, and North-East